dc.contributor.author |
Bedke, Jens |
|
dc.date.accessioned |
2023-12-22T08:44:56Z |
|
dc.date.available |
2023-12-22T08:44:56Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
2588-9311 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/148829 |
|
dc.language.iso |
en |
en |
dc.publisher |
Amsterdam : Elsevier |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.euo.2021.05.007 |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230925000000_04337 |
|
utue.publikation.seiten |
225-234 |
de_DE |
utue.personen.roh |
Rini, Brian I. |
|
utue.personen.roh |
Atkins, Michael B. |
|
utue.personen.roh |
Plimack, Elizabeth R. |
|
utue.personen.roh |
Soulieres, Denis |
|
utue.personen.roh |
McDermott, Raymond S. |
|
utue.personen.roh |
Bedke, Jens |
|
utue.personen.roh |
Tartas, Sophie |
|
utue.personen.roh |
Alekseev, Boris |
|
utue.personen.roh |
Melichar, Bohuslav |
|
utue.personen.roh |
Shparyk, Yaroslav |
|
utue.personen.roh |
Kondoh, Chihiro |
|
utue.personen.roh |
Langiewicz, Przemyslaw |
|
utue.personen.roh |
Wood, Lori A. |
|
utue.personen.roh |
Hammers, Hans |
|
utue.personen.roh |
Silber, Cynthia G. |
|
utue.personen.roh |
Haber, Barbara |
|
utue.personen.roh |
Jensen, Erin |
|
utue.personen.roh |
Chen, Mei |
|
utue.personen.roh |
Powles, Thomas |
|
dcterms.isPartOf.ZSTitelID |
European Urology Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
2 |
de_DE |
dcterms.isPartOf.ZS-Volume |
5 |
de_DE |
utue.fakultaet |
Universität Tübingen (ohne Fakultätsangabe) |
|